IL-17A and Multiple Sclerosis: Signaling Pathways, Producing Cells and Target Cells in the Central Nervous System

Current drug targets

Volumn 17, Issue 16, 2016, Pages 1882-1893

  Kolbinger, Frank ^b   Huppertz, Christine ^b   Mir, Anis ^b   Padova, Franco Di ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IL17A PROTEIN, HUMAN; INTERLEUKIN 17;

ANIMAL; ASTROCYTE; GLIA; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PATHOLOGY; PRECLINICAL STUDY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ASTROCYTES; CYTOKINES; DRUG EVALUATION, PRECLINICAL; HUMANS; INTERLEUKIN-17; MOLECULAR TARGETED THERAPY; MULTIPLE SCLEROSIS; NEUROGLIA; OLIGODENDROGLIA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84995461583     PISSN: None     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450117666160307144027     Document Type: Review

References (0)